Heart Failure Clinical Trial

The Inotrope Evaluation and Research Patient Registry

Summary

The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.

View Full Description

Full Description

Eligible patients will be consented by the site investigator or staff to participate in the Registry at the time of referral for home care. Clinical data, including dosing, symptom severity, lab values, and hospitalizations, along with data on quality-of-life and patient compliance with treatment, will be collected by the home care nurses and pharmacists. The Registry's goal is to significantly contribute to the medical understandings of heart failure treatment and to improve the quality of care for heart failure patients in the United States through active publication of registry findings and disease management approaches.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient must be prescribed inotropic treatment (milrinone, dobutamine or dopamine)
Patient must be referred to Coram for this treatment in an alternate site of care, either home or infusion suite
Patient must be willing to receive care and comply with the teaching and training necessary to administer treatment
Patient is age 18 or over

Exclusion Criteria:

Patient is unable to start, or stops taking, inotropic medication
Patient and/or patient insurance will not cover cost of home inotropic treatment with Coram, or patient elects not to start treatment
Patient is under the age of 18

Study is for people with:

Heart Failure

Estimated Enrollment:

129

Study ID:

NCT03160846

Recruitment Status:

Completed

Sponsor:

Coram Clinical Trials

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

University of Alabama at Birmingham
Birmingham Alabama, 35294, United States
Northwestern University, Bluhm Cardiovascular Institute
Chicago Illinois, 60611, United States
The University of Kansas Medical Center Research Institute
Kansas City Kansas, 66160, United States
Icahn School of Medicine at Mount Sinai
New York New York, 10029, United States
Columbia University Medical Center/Vivian and Seymour Milstein Family Heart Center
New York New York, 10032, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

129

Study ID:

NCT03160846

Recruitment Status:

Completed

Sponsor:


Coram Clinical Trials

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider